Systemic Safety of a Recombinant AAV8 Vector for Human Cocaine Hydrolase Gene Therapy: A Good Laboratory Practice Preclinical Study in Mice
Human Gene Therapy - United States
doi 10.1089/hum.2019.233
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Mary Ann Liebert Inc